73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
{{items.name}}
α-KG-dependent glycolysis activation by BCAT1 contributes to EGFR-TKI resistance in NSCLC
Oncology
α-KG-dependent glycolysis activation by BCAT1 contributes to EGFR-TKI resistance in NSCLC
November 28,2024
Latest Articles
Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of a
Updated on: February 20,2024
Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of a
Updated on:February 20,2024
Less invasive for patients: Using blood tests to diagnose lung cancer

Less invasive for patients: Using blood tests to diagnose lung cancer

by Eindhoven University of TechnologyCredit: Pixabay/CC0 Public DomainCurrently, when lung cancer is suspected, a "morsel" of tissue is removed and examined under the microscope. This m
Updated on: March 05,2024
Less invasive for patients: Using blood tests to diagnose lung cancer

Less invasive for patients: Using blood tests to diagnose lung cancer

by Eindhoven University of TechnologyCredit: Pixabay/CC0 Public DomainCurrently, when lung cancer is suspected, a "morsel" of tissue is removed and examined under the microscope. This m
Updated on:March 05,2024
A new treatment for acute myeloid leukemia could prove beneficial for even more people

A new treatment for acute myeloid leukemia could prove beneficial for even more people

by Peter MacCallum Cancer CentreAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainNew research published inScience Advancestoday conducted by researchers at Peter MacCallu
Updated on: February 20,2024
A new treatment for acute myeloid leukemia could prove beneficial for even more people

A new treatment for acute myeloid leukemia could prove beneficial for even more people

by Peter MacCallum Cancer CentreAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainNew research published inScience Advancestoday conducted by researchers at Peter MacCallu
Updated on:February 20,2024
Research uncovers potential pathway for breast cancer treatment

Research uncovers potential pathway for breast cancer treatment

by Elizabeth Chapin,University of KentuckyYadi Wu, Ph.D., University of Kentucky Markey Cancer Center. Credit: Ben Corwin/University of KentuckyA recent University of Kentucky Markey Cancer Cent
Updated on: March 20,2024
Research uncovers potential pathway for breast cancer treatment

Research uncovers potential pathway for breast cancer treatment

by Elizabeth Chapin,University of KentuckyYadi Wu, Ph.D., University of Kentucky Markey Cancer Center. Credit: Ben Corwin/University of KentuckyA recent University of Kentucky Markey Cancer Cent
Updated on:March 20,2024
Researchers discover potential new melanoma treatment, giving hope to patients

Researchers discover potential new melanoma treatment, giving hope to patients

by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t
Updated on: January 30,2024
Researchers discover potential new melanoma treatment, giving hope to patients

Researchers discover potential new melanoma treatment, giving hope to patients

by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t
Updated on:January 30,2024
Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ
Updated on: February 20,2024
Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ
Updated on:February 20,2024
Daily aspirin cuts odds for colon cancer: who benefits most?

Daily aspirin cuts odds for colon cancer: who benefits most?

by Ernie MundellIt's long been known that a daily dose of low-dose aspirin helps keepcolon cancerat bay.But new research suggests that those who benefit most are folks whose lifestyles
Updated on: August 27,2024
Daily aspirin cuts odds for colon cancer: who benefits most?

Daily aspirin cuts odds for colon cancer: who benefits most?

by Ernie MundellIt's long been known that a daily dose of low-dose aspirin helps keepcolon cancerat bay.But new research suggests that those who benefit most are folks whose lifestyles
Updated on:August 27,2024
State-of-the-art MRI technology bypasses need for biopsy

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI
Updated on: March 21,2024
State-of-the-art MRI technology bypasses need for biopsy

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI
Updated on:March 21,2024
Report suggests a big improvement in lung cancer survival

Report suggests a big improvement in lung cancer survival

by Carole Tanzer MillerMore people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows."There is more work to do, but I am incredi
Updated on: December 01,2024
Report suggests a big improvement in lung cancer survival

Report suggests a big improvement in lung cancer survival

by Carole Tanzer MillerMore people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows."There is more work to do, but I am incredi
Updated on:December 01,2024
Examining a potential second generation epigenetic therapy for advanced solid tumors

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec
Updated on: February 18,2024
Examining a potential second generation epigenetic therapy for advanced solid tumors

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec
Updated on:February 18,2024
AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac
Updated on: April 28,2024
AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac
Updated on:April 28,2024
More News
Categories
Allergy&Clinical immunology
Anesthesiology & Pain
Cardiovascular Diseases
Dermatology
Diabetes & Endocrinology
Emergency Medicine & Critical Care
ENT & HN
Family Medicine
Gastroenterology
General Surgery
Geriatrics
Hematology&Oncology
Infectious Diseases
Nephrology & Urology
Neurology
Nutrition
OB & GYN
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Plastic Surgery
Psychiatry & Mental Health
Public Health & Prevention
Pulmonology
Rheumatology
Stomatology
Sleep
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com